INS and hypertriglyceridemia: Moreover, when we excluded the subjects being in the use of oral hypoglycemic, lipid-lowing agents and insulin, or with severe hypertriglyceridemia, the ROC values did not appreciably alter compared to the analyses that included these participants (see Supplemental Tables S1 and S2).